Orthosiphon grandiflorum has a protective effect in a calcium oxalate stone forming rat model

Urological Research

Volumn 38, Issue 2, 2010, Pages 89-96

  Akanae, Wongsawat ^a   Tsujihata, Masao ^a   Yoshioka, Iwao ^a   Nonomura, Norio ^a   Okuyama, Akihiko ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Antioxidant; Kidney calculi; Orthosiphon grandiflorum; Oxidative stress; Urolithiasis

Indexed keywords

CATALASE; CITRATE POTASSIUM; PLANT MEDICINAL PRODUCT; SUPEROXIDE DISMUTASE;

ALKALINIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; IMMUNOFLUORESCENCE TEST; MALE; NONHUMAN; ORTHOSIPHON; ORTHOSIPHON GRANDIFLORUM; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RENAL PROTECTION; URINALYSIS; UROLITHIASIS; WESTERN BLOTTING;

ANIMALS; CALCIUM OXALATE; DISEASE MODELS, ANIMAL; KIDNEY CALCULI; MALE; ORTHOSIPHON; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77953284694     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00240-010-0265-6     Document Type: Article

References (39)

1. Ramello A, Vitale C, Marangella M (2000) Epidemiology of nephrolithiasis. J Nephrol 3:45-50
2. Sriboonlue P, Prasongwattana V, Chatta K, Tungsanga K (1992) Prevalence of upper urinary tract stone disease in a rural community of northeast Thailand. Br J Urol 69:240-244
3. Yanakawa M, Kawamura J, Onishi T et al (1997) Incidence of urolithiasis in northeast Thailand. Int J Urol 4:537-540
4. Coe FL, Evan A, Worcester E (2005) Kidney stone disease. J Clin Invest 115:2598-2608
5. Unakul S (1961) Urinary stones in Thailand: a statistical survey. Siriraj Hospital Gaz 13:199-214
6. Prasongwattana V, Sriboonlue P, Suntarapa S (1983) Urinary stone composition in northeast Thailand. Br J Urol 55:353-355
7. Osamu Y, Akito T, Tadashi O, Yusaku O (1999) Nation trend of the incidence of urolithiasis in Japan from 1965 to 1995. Kidney Int 56:1899-1904
8. Pearle MS, Calhoun EA, Curhan GC et al (2005) Urologic diseases in America project: urolithiasis. J Urol 173:848-857
9. Aeckart KSJ, Schroder FH (1989) Effect of extra corporeal shock wave lithotripsy (ESWL) on renal tissue. Urol Res 17:3-7
10. Touhami M, Laroubi A, Elhabazi K et al. (2007) Lemon juice has protective activity in a rat urolithiasis model. BMC Urol 5:7-18
11. Chin JH, Hussin AH, Ismail S (2009) Effect of Orthosiphon Stamineus leaf extracts on hepatic cytochrome P450, UGT and GST activity in STZ-induced diabetic rats. J Adv Sci Arts 1(1)
12. Lyckender IM, Malterud KE (1996) Lipophillic flavonoids from Orthosiphon Stamineus prevent oxidative inactivation of 15-lipoxygenase. Prostaglandins Leukot Essent Fatty Acids 54(4):239-246
13. Malterud KE, Rydland KM (2000) Inhibition of 15-lipoxygenase from orange peel. J Agri Food Chem 48(11):5576-5580
14. Takeda Y, Matsumoto T, Terao H et al (1993) Orthosiphol D and E minor diterpenes from Orthosiphon Stamineus. Phytochemistry 33(2):411-415
15. Tezuka Y, Stampoulis P, Banskota AH et al (2000) Constituents of the Vietnamese medical plant Orthosiphon Stamineus. Chem Pharm Bull 48(11):1711-1719
16. Sumaryono W, Proksch P, Wray V et al (1991) Qualitative and quantitative analysis of the phenolic constituents from Orthosiphon Stamineus. Plant Med 57:176-180
17. RPark HK, Jeong BC, Sung MK, Park MY et al (2008) Reduction of oxidative stress in cultured renal tubular cells and preventive effects on renal stone formation by the bioXavonoid quercetin. J Urol 179(4):1620-1626
18. Jeong BC, Kim BS, Kim JI, Kim HH (2006) Effects of green tea on urinary stone formation: an in vivo and in vitro study. J Endourol 20(5):356-361
19. Kalidas S, Gopinadhan P, Anthony P, Robert EL (2006) 2.11 Rosmarinic acid biosynthesis and mechanism of action. In: Food biotechnology 2nd edn. Mortimer, London
20. Premgamone A, Sriboonlue P, Disatapornjaroen W et al (2001) A long-term study on the efficacy of a herbal plant, Orthosiphon grandiflorus, and sodium potassium citrate in renal calculi treatment. Southeast Asian J Trop Med Public Health 32(3):654-660
21. Robinson MR, Leitao VA, Haleblian GE, Scales CD Jr, Chandrashekar A, Pierre SA, Preminger GM (2009) Impact of long-term potassium citrate therapy on urinary profiles and recurrence stone formation. J Urol 181(3):1145-1150
22. Ogawa Y, Machida N, Ogawa T et al (2006) Calcium oxalate supersaturation in dialysis patients with and without primary hyperoxaluria. Urol Res 34(1):12-16
23. Luke MN (2007) Quantifying western blots without expensive commercial quantification software. In: Miscellaneous topics all vaguely related to science. http://www.lukemiller.org/journal/2007/08/quantifying-western-blots- without.html. Accessed 01 August 2007
24. Churchill DN (1987) Medical treatment to prevent recurrent calcium urolithiasis: a guide to critical appraisal. Miner Electrolyte Metab 13:294-304
25. Preminger GM (1992) Renal-calculi: pathogenesis, diagnosis, and medical therapy. Semin Nephrol 12:200-216
26. Mattle D, Hess B (2005) Preventive treatment of neprolithiasis with alkali citrate: a critical review. Urol Res 33(2):73-79
27. Preminger GM, Sakhaee K, Pak CY (1988) Alkali action on the urinary crystallization of calcium salts: contrasting responses to sodium citrate and potassium citrate. J Urol 139(2):240-242
28. Barcelo P, Wuhl O, Servitge E, Rousaud A, Park CY (1993) Randomized double-blind study of potassium citrate in idiopathic hypocitrauric calcium nephrolithiasis. J Urol 150(6):1761-1764
29. Stevenson AE, Robertson WG, Markwell P (2003) Risk factor analysis and relative supersaturation as tools for identifying calcium oxalate stone-forming dogs. J Small Anim Pract 44(11): 491-496
30. Carvalho M, Vieira MA (2004) Changes in calcium oxalate crystal morphology as a function of supersaturation. Int Braz J Urol 30(3):205-209
31. Miller C, Kennington L, Cooney R et al (2000) Oxalate toxicity in renal epithelial cells: characteristics of apoptosis and necrosis. Toxicol Appl Pharmacol 162:132-141
32. Thamilselvan S, Khan SR (1998) Oxalate and calcium oxalate crystals are injurious to renal epithelial cells: results of in vivo and in vitro studies. J Nephrol 11(1):66-69
33. Khan SR, Byer KJ, Thamilselvan S et al (1999) Crystal-cell interaction and apoptosis in oxalate-associated injury of renal epithelial cells. J Am Soc Nephrol 10(14):457-463
34. Tsujihata M, Momohara C, Yoshioka I, Tsujimura A, Nonomura N, Okuyama A (2008) Atorvastatin inhibits renal crystal retention in a rat stone forming model. J Urol 180(5):2212-2217
35. Schriner SE, Ogburn CE, Smith AC et al (2000) Level of DNA damage are unaltered in mice overexpressing human catalase in nuclei. Free Radic Biol Med 29(7):664-673
36. Calişkan-Can E, Firat H, Ardiç S, Simşek B, Torun M, Yardim-Akaydin S (2008) Increased levels of 8-hydroxydeoxyguanosine and its relationship with lipid peroxidation and antioxidant vitamins in lung cancer. Clin Chem Lab Med 46(1):107-112
37. Nijveldt RJ, van Nood E, van Hoorn DE et al (2001) Flavonoids: a review of probable mechanism of action and potential applications. Am J Clin Nutr 74(4):418-425
38. Itoh Y, Yasui T, Okada A et al (2005) Preventive effects of green tea on renal stone formation and the role of oxidative stress in nephrolithiasis. J Urol 173(1):271-275
39. Khan SR (2005) Hyperoxaluria-induced oxidative stress and anti-oxidants for renal protection. Urol Res 33(5):349-357